+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

From
MEK Inhibitor Market - Global Forecast 2026-2032 - Product Thumbnail Image

MEK Inhibitor Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
From
From
BRAF Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

BRAF Inhibitors Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Antitumor ADC Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antitumor ADC Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Targeted Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Targeted Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 185 Pages
  • Global
From
Immuno-oncology Clinical Trials Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-oncology Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 191 Pages
  • Global
From
Head & Neck Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Head & Neck Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 189 Pages
  • Global
From
From
Cancer Biological Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Biological Therapy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
Oncology Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Liver Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Liver Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
Combination Antibody Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Combination Antibody Therapy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 194 Pages
  • Global
From
Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
Urothelial Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Urothelial Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Immuno-Oncology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Blood Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Blood Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more